Gianni Biancofiore, Giorgio Della Rocca, Lucia Bindi, Anna Romanelli, Massimo Esposito, Luca Meacci, Lucio Urbani, Franco Filipponi, Franco Mosca – 23 July 2004 – With the aim of assessing whether fenoldopam can help to preserve renal function after liver transplantation, we randomized 140 consecutive recipients with comparable preoperative renal function to receive fenoldopam 0.1 μg/kg/minute (group F, 46 patients), dopamine 3 μg/kg/minute (group D, 48 patients), or placebo (group P, 46 patients) from the time of anesthesia induction to 96 hours postoperatively.

Uwe J.F. Tietge, Oliver Selberg, Andreas Kreter, Matthias J. Bahr, Matthias Pirlich, Wolfgang Burchert, Manfred J. Müller, Michael P. Manns, Klaus H.W. Böker – 23 July 2004 – With increasing long‐term survival rates after orthotopic liver transplantation (OLT), metabolic alterations complicating the clinical course, such as diabetes mellitus (DM), become increasingly important. Liver cirrhosis is associated with severe alterations in glucose metabolism. However, it is currently unclear whether these changes are reversed by successful OLT.

Stefan A. Topp, Gundumi A. Upadhya, Steven M. Strasberg – 23 July 2004 – Cold preservation of rat sinusoidal endothelial cells causes actin disassembly, cell rounding, matrix metalloproteinase (MMP) secretion, and platelet adhesiveness. Studies in rats suggest that gelatinases MMP2 and MMP9 are the key mediators of the injury. We created a model of cold preservation injury in mouse sinusoidal endothelial cell (MSEC) to examine the effect of cold on MSEC, specifically on MSEC from genetically deleted mice (MMP9/KO) mice.

Ryan A. McTaggart, Norah A. Terrault, Andrew J. Vardanian, Alan Bostrom, Sandy Feng – 23 July 2004 – Although recurrent hepatitis C (HCV) occurs universally after liver transplantation (LT), its tempo and severity are variable and unpredictable. Diagnosis and treatment of early acute rejection (EAR) likely affect the course of recurrent HCV disease. We have studied a contemporary cohort of LT recipients to reexamine risk factors for EAR. We hypothesized that HCV etiology may represent a significant risk factor for EAR for many reasons.

Mark W. Russo, Joseph A. Galanko, Roshan Shrestha, Michael W. Fried, Paul Watkins – 23 July 2004 – Studies of acute liver failure from drugs have included cases mostly attributed to acetaminophen (APAP) but have reported limited data on other drugs. We used the United Network for Organ Sharing (UNOS) liver transplant database from 1990 to 2002 to identify recipients and estimate a U.S. population‐based rate of liver transplantation due to acute liver failure from drugs. Patients were identified if their diagnosis was acute hepatic necrosis from an implicated drug at the time of transplant.

Vivian S. Lee, Glyn R. Morgan, Jennifer C. Lin, Carol A. Nazzaro, Jerry S. Chang, Lewis W. Teperman, Glenn A. Krinsky – 23 July 2004 – Our objective was to investigate the coexistence of vascular and biliary anatomic variants, the latter of which are known to increase the risk of biliary complications in living liver donor transplantation.

30 June 2004

30 June 2004

Zachary D. Goodman – 30 June 2004

Jayant A. Talwalkar, Paul Angulo, C. Daniel Johnson, Bret T. Petersen, Keith D. Lindor – 30 June 2004 – Investigations examining the use of magnetic resonance cholangiography (MRC) for the diagnosis of primary sclerosing cholangitis (PSC) have described comparable accuracy when compared to endoscopic retrograde cholangiopancreatography (ERCP). The effectiveness of MRC based on overall cost, however, remains unknown. Our aim was to determine the average cost per correct diagnosis using MRC or ERCP as the initial testing strategy for the diagnosis of PSC.